Curio Wealth’s NanoViricides NNVC Stock Holding History

Curio Wealth’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$1.82K	–	773
2026 Q1	$1.82K	Hold	2,000	–	–	﹤0.01%	323
2025 Q4	$2.38K	Buy	+2,000	New	+$2.81K	﹤0.01%	336

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Curio Wealth's NNVC Position: Q2 2026 in Review

Curio Wealth sold out of NanoViricides (NNVC) in Q2 2026, closing a stake of 2,000 shares — an estimated $1.82K sold.

Curio Wealth first reported a position in NNVC in Q4 2025 and held it in 2 quarters. The position peaked at $2.38K in Q4 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Curio Wealth reported no remaining NanoViricides position as of Q2 2026 after selling out during the quarter.
Curio Wealth sold 2,000 NanoViricides shares in Q2 2026, an estimated $1.82K.
Curio Wealth first reported a position in NanoViricides in Q4 2025 and held it in 2 quarters.
Curio Wealth's NanoViricides position peaked at $2.38K in Q4 2025.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.